Enzo Life Sciences, Inc.

Enzo Life Sciences - Innovative life science research reagents

Enzo Life Sciences, Inc., a wholly owned subsidiary of Enzo Biochem, Inc. with its headquarters in Farmingdale, New York, is renowned for its pioneering work in the field of innovative life science research reagents. The company is structured to spearhead the global development, production, marketing, and sales of such reagents, drawing on over 30 years of successful experience that has established strong international market recognition. This success is underpinned by exceptional operational capabilities and the creation of a cutting-edge electronic information and ordering marketplace.

Enzo Life Sciences, Inc. stands out as a leader in labeling and detection technologies across research and diagnostic markets. Their robust portfolio, encompassing proteins, antibodies, peptides, small molecules, labeling probes, dyes, and kits, equips life science researchers with essential tools for target identification/validation, high content analysis, gene expression analysis, nucleic acid detection, protein biochemistry and detection, as well as cellular analysis.

With over 45 years of experience, Enzo Biochem has been at the forefront of innovation and product development, catering to diverse needs in biomedical research and healthcare. Their comprehensive portfolio, featuring 20,000 high-quality products such as antibodies, genomic probes, assays, biochemicals, and proteins, supports the endeavors of academic research centers and industry partners globally. Enzo's proprietary products and technologies play pivotal roles in translational research and drug development across genomic analysis, protein analysis, cellular analysis, tissue analysis, and small molecule chemistry. The company holds a broad and deep intellectual property portfolio, with patent coverage extending to key enabling technologies.

Enzo Biochem, as a leading life sciences and biotechnology company, concentrates on leveraging genetic processes to create research tools, diagnostics, and therapeutics. Established in 1976, the company has focused on developing enabling technologies in gene regulation and gene modification. Many of these technologies find applications in biomedical and pharmaceutical research, serving as a foundation for entry into the clinical diagnostics market. Enzo's technologies and products are widely recognized as essential tools for non-radioactive gene labeling in use by researchers worldwide. Their contributions to gene analysis have led to the development of significant therapeutic candidates for treating viral and immunological disorders, some of which are progressing through human clinical trials. Enzo Biochem holds a substantial patent position, with numerous pioneer patents and applications covering core technologies resulting from extensive research and development activities.

The business operations of Enzo Biochem are carried out through its three wholly owned subsidiaries: Enzo Life Sciences, Enzo Therapeutics, and Enzo Clinical Labs. These activities encompass research and development, manufacturing, and marketing of biomedical research products and tools through Enzo Life Sciences, research and development of therapeutic products through Enzo Therapeutics, and the operation of a regional clinical reference laboratory through Enzo Clinical Labs.

Enzo's foresight in recognizing the importance of recombinant DNA technology as an informational source over two decades ago has evolved into a significant direction in modern medicine.

Search for products by ENZO Life Sciences